Hope Biosciences
16700 Creek Bend Dr.
Sugar Land
Texas
77478
United States
Website: https://www.hope.bio/
Email: info@hope.bio
13 articles about Hope Biosciences
-
Hope Biosciences’ Cell Therapy Shown Safe, Beneficial for Rheumatoid Arthritis
3/8/2022
Hope Biosciences’ adipose-derived mesenchymal stem cells are effective in improving joint function in patients actively suffering from Rheumatoid Arthritis, finds a FDA-authorized Phase I/IIa pilot trial.
-
FDA Authorizes Novel Stem Cell Trial for Parkinson’s
4/28/2021
Houston-area non-profit Hope Biosciences Stem Cell Research Foundation (HBSCRF) has received FDA authorization for a Phase II double-blind placebo controlled clinical trial to assess the efficacy and safety of multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells to improve activities of daily living and quality of life in subjects with Parkinson’s Disease.
-
Texas is quickly becoming a hotbed of biopharmaceutical activities, with Houston being one of the two top cities in the state that is leading the way.
-
Company Profile for Hope Biosciences Stem Cell Research Foundation
2/22/2021
Hope Biosciences Stem Cell Research Foundation, administered through the Greater Houston Community Foundation, was founded to address the need to accelerate translational research in regenerative medicine so that therapies could be delivered to patients faster.
-
Hope Biosciences Stem Cell Research Foundation Completes First Treatments for COVID-19
4/23/2020
Hope Biosciences Stem Cell Research Foundation (HBSCRF) successfully completes the first ten treatments for immune support against COVID-19. This is the first of three FDA-approved clinical trials targeting COVID-19 that the foundation is executing. The first study is providing autologous, adipose-derived mesenchymal stem cells ( HB-adMSCs ) to patients who have alr
-
Hope Biosciences Announces Third FDA-approved Clinical Trial for COVID-19
4/21/2020
Hope Biosciences announces FDA approval on their third clinical trial for COVID-19. This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics . The hospital has an entire floor dedicated to treating COVID-19 patients, with staff specifically trained to care for these patients.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 21, 2020.
-
Hope Biosciences Receives Second FDA Clearance for a Phase II Clinical Trial for Protection Against COVID-19
4/13/2020
Hope Biosciences , a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease , today announced that FDA has approved a Phase II clinical trial evaluating the safety and efficacy of Hope Biosciences’ allogeneic, adipose-derived mesenchymal stem cells (HB-adMSCs) to pro
-
Hope Biosciences Receives FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19
4/6/2020
Hope Biosciences, today announced that FDA has approved a Phase II clinical trial evaluating efficacy and safety of Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) to provide immune support against COV
-
Hope Biosciences Receives FDA Approval to Commence Groundbreaking Stem Cell Clinical Trial for Alzheimer’s Disease
11/20/2019
Partnering with Altoida, Inc. to Leverage Predictive Digital Biomarkers for Detection of Mild Cognitive Impairment due to Alzheimer’s Disease
-
Hope Biosciences Opens First Phase I/II Stem Cell Trial for Brain Injury Treatment
10/16/2019
Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic diseases, today announced that enrollment is now open for a Phase I/II trial evaluating safety and efficacy of Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) for Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy (brain injury caused by oxygen deprivation to the brain)
-
VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences
10/9/2019
Study protocol incorporates remote visits via VirTrial’s telehealth platform.
-
Hope Biosciences Release: Company Licenses Nuc-Gemcitabine, A 'Trojan Horse' Anti-Nucleolin-Gemcitabine Aptamer Drug Conjugate Against Cancer
1/23/2017